Content area
Full Text
Published online: 2 December 2021
© Springer Nature 2021
Correction to:
American Journal of Cardiovascular Drugs (2021) 21:701-710
https://doi.org/10.1007/s40256-021-00503-8
The article titled "Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction", written by Hannah A. Blair was originally published Online First without open access. After publication in volume 21, issue 6, pages 701-710, the Authors requested that the article be made an open access publication on November 23rd. Open access for this paper was funded by AstraZeneca.
This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International...